Research.Patient.info
Immune Thrombocytopenia (ITP) research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE2, PHASE3
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
This study is looking into a new medicine called efgartigimod for young people aged 12 to 17 with a blood condition called chronic ITP. The aim is to find the best dose to help increase their platelet count and manage their condition.
Germany · Italy · Poland - active not recruitingPHASE1, PHASE2
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
This study looks at a new medicine called povetacicept for adults with rare blood conditions like Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (wAIHA), and Cold Agglutinin Disease (CAD). Researchers want to see if it's safe and helps improve these conditions.
United States · Australia · Austria